Somatuline Autogel (lanreotide): Reviews and patient testimonials
Medication indications
Somatuline Autogel 60mg, Somatuline Autogel 90mg, Somatuline Autogel 120mg
Somatuline Autogel is indicated for:
• The treatment of individuals with acromegaly when the circulating levels of Growth Hormone (GH) and/or Insulin-like Growth Factor-1 (IGF-1) remain abnormal after surgery and/or radiotherapy, or in patients who otherwise require medical treatment. The goal of treatment in acromegaly is to reduce GH and IGF-1 levels and where possible to normalise these values.
• The treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) gastroenteropancreatic neuroendocrine tumours (GEP-NETs) of midgut, pancreatic or unknown origin where hindgut sites of origin have been excluded, in adult patients with unresectable locally advanced or metastatic disease.
• The treatment of symptoms associated with neuroendocrine (particularly carcinoid) tumours.
Molecule: lanreotide
Patients' opinions on Somatuline Autogel
In brief
General satisfaction level: 7.67/10 Learn more
Treatment's effectiveness: 9.67/10 Learn more
Ease of use: 5.67/10 Learn more
Adherence to prescription: 8.67/10 Learn more
Detected side effects: 5.67/10 Learn more
Improvement in the quality of life: 8.00/10 Learn more
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.